x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr. Chapa"s OBGYN No Spin Podcast

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! PLUS...we believe that medical education should be delivered without any SPIN...Welcome, to Dr. Chapa"s OBGYN No Spin Podcast! (Note: our Legacy podcast, Clinical Pearls, will no longer have new episodes uploaded through

education medicine

All Episodes

20:33

WARNING: DepoP and Meningiomas

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/18

Depo-Provera was approved in 1992 by U.S. regulators. About 1 in 4 sexually active women in the United States have used the shot at some point, according to the U.S. Centers for Disease Control and Prevention (CDC). Meningiomas are common intracranial tumors with a female predominance. In fact, they are the most common primary brain tumor in women, with an incidence of approximately 12.76 per 100,000 in the general female population. The vast majority of these tumors are benign (World Health

en

19:11

Lube It Up For Baby Delivery?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/17

The second stage of labor, characterized by active pushing and the descent of the fetal head, can be a challenging and prolonged phase for both mother and baby. Various interventions have been explored to optimize this stage, and one such technique involves the application of vaginal lubricants. The rationale behind this approach is to reduce friction between the fetal head and the birth canal, potentially leading to smoother and faster delivery. Does this seemingly simple technique work? Does the

en

13:50

The 2 New FDA Approved GC Meds

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/15

Within the last few days, there has been breaking news regarding the war on gonorrhea. (zoliflodacin) was FDA approved on December 13, 2025, and Blujepa (gepotidacin) was FDA approved on December 11, 2025.These new oral treatments are particularly important given the global rise in gonococcal drug resistance and the convenience they offer over injectable options, potentially improving patient adherence and public health outcomes. Listen in for details.1. FDA News Release. FDA Approves Two Oral

en

16:24

Delayed Cord Clamping UPDATE (With Med Student Guest...

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/13

It’s so interesting to see how medical evidence evolves, and changes, over time. The result of course is that clinical practice evolves and changes as well. The story of umbilical cord management at time of delivery highlights this very issue very well. The ACOG first recommended delayed cord clamping (DCC) in 2012, for preterm infants, as data showed marked improvement in neonatal outcomes in that population. In this episode, we will briefly walk through the timeline from 2012 to the latest update

en

24:38

Continue Metformin in 1st T for PCOS?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/11

Podcast Family, we have covered PCOS on this show many times in the past; and yet- again, there is new information! A new publication from AJOG (Gray journal) describes a new meta-analysis on preconception/continued metformin use in the first trimester. Is this helpful? How does this contrast with the 2023 international guidance update on PCOS? Listen in for details. 1. ASRM: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary

en

22:25

No OB Hep C RX: Time For Change

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/08

Major health organizations, including the CDC and ACOG, recommend universal Hepatitis C Virus (HCV) screening for all pregnant women during each pregnancy and at time of delivery. Ideally, pregnant women should be screened for hepatitis C virus infection at the first prenatal visit of each pregnancy. If the antibody screen result is positive, hepatitis C virus RNA polymerase chain reaction testing is done to confirm the diagnosis. The risk of perinatal transmission of HCV is up to 9%, with at least

en

19:58

Freebirth, Wildbirth, and the Price of Autonomy

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/07

Welcome to the no spin podcast. In today's episode, we're tackling a subject that's gaining traction but carries significant risks: the freebirth and wildbirth movement. We'll explore the rising trends of unassisted childbirth, where individuals choose to forgo professional medical care during labor and delivery- or during the prenatal period altogether, and the potential devastating outcomes associated with these practices. Join us as we unpack the motivations behind these choices, the lack of

en

18:22

ACS Update on Self Collected VAGINAL HPV Tests

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/05

In 2024, the ASCCP updated their guidance to include Dual Stain technology as part of primary HPV cervical cancer screening. Now, on December 4, 2025, the ACS has updated their guidance regarding patient self-collection of vaginal specimens for primary HPV screening. This is fascinating and proves medicine moves fast! Should a negative self-collection test result have a repeat screen in 1, 3 or 5 years, or later? Listen in for details.1. Self-collected vaginal specimens for human papillomavirus

en

31:15

The Reverse Løvset Maneuver For SD

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/03

In the original Løvset maneuver (described for breech presentations), the fetus is rotated in one direction to facilitate arm delivery. For shoulder dystocia, the reverse Løvset applies rotation in the opposite direction—specifically rotating the posterior shoulder toward a "belly down" position through up to 180 degrees of rotation. These maneuvers were first described by Norwegian obstetrician Jørgen Løvset in the 1940s. Now, in the current November 2025 AJOG, this maneuver is back in the

en

21:31

Titrated Oral MISO Solution For Labor Augmentation?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/12/01

Misoprostol, as an E1 prostaglandin, is primarily used in obstetrics for cervical ripening (when the Bishop Score is under 6) and/or for labor INDUCTION (to begin labor). IV oxytocin is the principal agent used to augment labor, as needed, once labor has begun. In the US, misoprostol is not typically used after 4-6 cm cervical dilation. However, in a patient who requires augmentation, and who declines Pitocin while asking or oral misoprostol, can that be used? Is that evidence-based? The data may

en

24:48

IUD, Cytology, and Actinomyces: Management.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/30

Actinomyces species are considered part of the normal vaginal and urogenital tract flora. The percentage of Pap smears containing Actinomyces-like organisms varies but is most commonly reported as approximately 7% among women using IUDs. That number is supported by multiple sources, including the Infectious Diseases Society of America guideline and several clinical studies. The incidence can be higher or lower depending on the type of IUD; for example, copper IUDs have been associated with rates up

en

17:13

LDA for Unexplained Recurrent SABs?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/26

Recurrent pregnancy loss (RPL) affects approximately 5% of couples and is an emotional burden on those affected. There is some evidence that vaginal progesterone supplementation may be considered in patients with recurrent pregnancy loss who are experiencing vaginal bleeding during the first trimester. But what about prophylactic low dose aspirin in the first trimester, or preconceptionally, for unexplained RPL? Is that evidence-based? A new publication from the SMFM’s journal Pregnancy has examined

en

27:48

Change Gloves After Placenta at CS? Yes, and No.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/24

Having data is sometimes different than having clinically applicable data. This is exactly the issue with the proposed plan to reduce surgical site infection (SSI) by changing surgical gloves after placental delivery at C-Section. Just 24 hours ago, we received the question from a PGY4 OBGYN resident asking whether the practice of changing surgical gloves at C-Section after placental delivery to reduce SSI was evidence-based. So, in this episode, we will review the data - which is timely since this

en

24:45

Refresher of Genetic MD

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/21

Muscular dystrophy (MD) is a group of genetic diseases that affect about 16 to 25 per 100,000 people in the US, with the most common childhood form being Duchenne muscular dystrophy (DMD) and the most common adult form being myotonic dystrophy. The prevalence of DMD is estimated at around 1 in 3,500 live male births. Prenatal carrier screening for this is part of the ACMG Tier 3 expanded carrier panel. This is different from spinal muscular atrophy (SMA). As we recently had a patient who was a MD

en

35:42

Use GA at CS Electively? Maybe, Maybe.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/19

Regional anesthesia, typically with a spinal or epidural, has long been favored for cesarean births due in part to concerns about the effects that general anesthesia (GA) may have on newborns at delivery. However, data has shown that up to 1 in 6 women may experience pain with a “topped-off” labor epidural, during the cesarean. A new publication in the journal Anesthesia is now being interpreted as implying that general anesthesia may be a valid alternative electively. Is that what this new study

en

19:38

Lido Patches After CS? Maybe.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/18

The US has no shortage of lidocaine patch television commercials. Topical lidocaine has a role for local, topical, minor aches and pains. What about lidocaine patches for post-op cesarean section pain? Is there data for that? A brand-new meta-analysis in AJOG-MFM (Nov 13, 2025) looks at this option. However, there has been 3 prior reviews on the same topic from 2019, 2022, and 2023. Do they all arrive at the same result? Listen in for details!1. Smoker J, Cohen A, Rasouli MR, Schwenk ES. Transdermal

en

30:46

More Measles Material

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/17

Podcast Family, we have covered the subject of Measles previously on this show (links below). Those episodes were a preview of what has now been released ahead of print as a narrative review in the Green Journal! In this episode, we will summarize the KEY points of measles infection in pregnancy and re-state the “rule of 4” and the importance of the number 10 regarding this.1. Feb 24, 2025: Measles 101: https://open.spotify.com/episode/4lXrpqKTJPdDcTXPxpEmcb2. April 27, 2019: Measles!! ACOG Practice

en

17:44

Self-Hypnosis For Hot Flash Relief.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/12

The term "hypnosis" was first described in 1843 by Scottish surgeon James Braid, who published the book Neurypnology. He coined the term "hypnosis" from the Greek word for sleep to describe the trance-like state induced by focusing on a bright object. Self-hypnosis has now been shown to aid in menopausal hot flash reduction! In this episode, we will review this brand new publication from JAMA Network which confirmed via a multicenter RCT that a simple daily hypnosis audio session was effective for

en

31:46

That’s So Random!

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/12

Well, from time to time we cover RANDOM tidbits of information which cover RANDOM questions and/or RANDOM patient care issues that we encounter. In this episode we will cover one OB issue related to recurrent pregnancy loss, one GYN issue related to unilateral breast swelling in a patient with SLE, and one RANDOM life perspective response from a mock interview that I participated in for a residency candidate. Listen in for details!1. Factor V and recurrent pregnancy loss: de Assis, Viviana DO;

en

14:48

HISTORY MADE: New HRT News TODAY (11/10/25)

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/10

On August 15, 2025, we reviewed the data from an FDA expert panel calling on the FDA to remove the exiting Black Box warning on commercial HRT options for menopausal care. In a historic decision, this happened today. Listen in for details! 1. https://www.cbsnews.com/video/fda-chief-explains-changes-to-black-box-warnings-on-some-hormone-therapies-for-menopause/2. https://www.hhs.gov/press-room/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy.html

en

71 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College